fulvestrant has been researched along with Medulloblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belcher, SM; Le, HH; Ma, X | 1 |
| Ochoa, A; Reiss, K; Waligorska, A; Waligorski, P; Wilk, A | 1 |
2 other study(ies) available for fulvestrant and Medulloblastoma
| Article | Year |
|---|---|
Blockade of estrogen receptor signaling inhibits growth and migration of medulloblastoma.
Topics: Adolescent; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Cerebellar Neoplasms; Child; Child, Preschool; Down-Regulation; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Infant; Male; Medulloblastoma; Mice; Mice, Nude; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Signal Transduction; Xenograft Model Antitumor Assays | 2009 |
Inhibition of ERĪ² induces resistance to cisplatin by enhancing Rad51-mediated DNA repair in human medulloblastoma cell lines.
Topics: Antineoplastic Agents; Base Sequence; Cell Line, Tumor; Cell Survival; Cisplatin; DNA Damage; DNA Repair; Drug Interactions; Drug Resistance, Neoplasm; Estradiol; Estrogen Antagonists; Estrogen Receptor beta; Fulvestrant; Humans; Medulloblastoma; Rad51 Recombinase; RNA, Small Interfering | 2012 |